DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR NALTREXONE HYDROCHLORIDE
Clinical Trials for Naltrexone Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000195 | Neurobiology of Opioid Dependence: 4 - 4 | Withdrawn | National Institute on Drug Abuse (NIDA) | Phase 2 | 1993-01-01 | The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers. |
| NCT00000195 | Neurobiology of Opioid Dependence: 4 - 4 | Withdrawn | Yale University | Phase 2 | 1993-01-01 | The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers. |
| NCT00000196 | Neurobiology of Opioid Dependence: 5 - 5 | Withdrawn | National Institute on Drug Abuse (NIDA) | Phase 2 | 1993-01-01 | The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers. |
| NCT00000196 | Neurobiology of Opioid Dependence: 5 - 5 | Withdrawn | Yale University | Phase 2 | 1993-01-01 | The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers. |
| NCT00000230 | Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 1995-01-01 | The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with naltrexone. |
| NCT00000230 | Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12 | Completed | University of Vermont | Phase 2 | 1995-01-01 | The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with naltrexone. |
| NCT00000231 | Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13 | Completed | University of Vermont | Phase 2 | 1992-02-01 | The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with pro-social activities. In addition, we will examine whether blind naltrexone dosing is effective in indicating naltrexone consumption. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Naltrexone Hydrochloride
Clinical Trial Locations for Naltrexone Hydrochloride
Trials by Country
Clinical Trial Progress for Naltrexone Hydrochloride
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Naltrexone Hydrochloride
Sponsor Name
